Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160055/S056

RxSight Light Adjustable Lens and Light Delivery Device

Rxsight, Inc. · Decision date Sep 3, 2026

MEDTECHLEDGER EXPLANATIONP160055/S056

What did the FDA approve?

The FDA record lists P160055/S056 as an approval dated 2026-09-03 for Rxsight, Inc., under product code PZK in the ophthalmic specialty. The supplement type is Real-Time Process, with the reason given as Change Design/Components/Specifications/Material. Because the identifier ties S056 to PMA P160055, the decision amends that existing approval rather than approving the RxSight Light Adjustable Lens and Light Delivery Device system anew.

The supplied statement covers updates to Light Delivery Device Model 61002-006 and Model 61002-007 software: minor graphical user interface enhancements, changes to internal manufacturing and service tools, software processing optimizations, and resolution of identified bugs. The statement does not specify which bugs, what the GUI changes alter, or how the optimizations affect device function, so those details remain unknown, and the record itself does not establish safety or clinical effectiveness.

FDA approval order statement

Approval for updates to the Light Delivery Device (LDD) Model 61002-006 software and Model 61002-007 software that include minor enhancements to the graphical user interface (GUI), improvements to internal manufacturing and service tools, software processing optimizations, and resolution of identified bugs
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Ophthalmic
Decision date
Sep 3, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P160055/S056
Regulatory pathway
PMA supplement
Applicant
Rxsight, Inc.
Product code
PZK
Decision code
APPR
Decision date
Sep 3, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Light adjustable lens (LAL) and light delivery device (LDD).

Applicant
Rxsight, Inc.
Product code
PZK
FDA device class
3

For the original device and its historical approval scope, see PMA P160055. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P160055 · Original PMA

    LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)

  2. P160055/S056 received

    Application receipt date recorded by FDA.

  3. P160055/S056 · FDA decision

    Real-Time Process

  4. P160055/S058 · Related supplement

    RxSight Light Adjustable Lens and Light Delivery Device

  5. P160055/S057 · Related supplement

    RxSight Light Adjustable Lens and Light Delivery Device

Timeline entries are records held by MedtechLedger for P160055. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160055

Product / regulatory recordCompanyPathwayDecision dateSource
Rxsight, Inc.PMA approvalNov 22, 2017FDA
Rxsight, Inc.PMA supplementOct 22, 2026FDA
Rxsight, Inc.PMA supplementNov 5, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Rxsight, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
100 Columbia, Aliso Viejo, CA, 92656

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records